Literature DB >> 23777661

Recapitulation of the hepatitis C virus life-cycle in engineered murine cell lines.

Alexander Vogt1, Margaret A Scull, Tamar Friling, Joshua A Horwitz, Bridget M Donovan, Marcus Dorner, Gisa Gerold, Rachael N Labitt, Charles M Rice, Alexander Ploss.   

Abstract

Hepatitis C virus (HCV) remains a major medical problem. In-depth study of HCV pathogenesis and immune responses is hampered by the lack of suitable small animal models. The narrow host range of HCV remains incompletely understood. We demonstrate that the entire HCV life-cycle can be recapitulated in mouse cells. We show that antiviral signaling interferes with HCV RNA replication in mouse cells. We were able to infect mouse cells expressing human CD81 and occludin (OCLN)-the minimal set of entry factor factors required for HCV uptake into mouse cells. Infected mouse cells sustain HCV RNA replication in the presence of miR122 and release infectious particles when mouse apoE is supplied. Our data demonstrate that the barriers of HCV interspecies transmission can be overcome by engineering a suitable cellular environment and provide a blue-print towards constructing a small animal model for HCV infection.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  HCV animal model; Hepatitis C virus; Innate immunity; Species tropism; Viral assembly; Viral entry

Mesh:

Year:  2013        PMID: 23777661      PMCID: PMC3755106          DOI: 10.1016/j.virol.2013.05.036

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  67 in total

1.  Common seed analysis to identify off-target effects in siRNA screens.

Authors:  Shane Marine; Amit Bahl; Marc Ferrer; Eugen Buehler
Journal:  J Biomol Screen       Date:  2011-11-15

Review 2.  Hepatitis C virus replication cycle.

Authors:  Ralf Bartenschlager; Francois-Loic Cosset; Volker Lohmann
Journal:  J Hepatol       Date:  2010-06-01       Impact factor: 25.083

Review 3.  Animal models for the study of hepatitis C virus infection and related liver disease.

Authors:  Jens Bukh
Journal:  Gastroenterology       Date:  2012-05       Impact factor: 22.682

4.  Bright far-red fluorescent protein for whole-body imaging.

Authors:  Dmitry Shcherbo; Ekaterina M Merzlyak; Tatiana V Chepurnykh; Arkady F Fradkov; Galina V Ermakova; Elena A Solovieva; Konstantin A Lukyanov; Ekaterina A Bogdanova; Andrey G Zaraisky; Sergey Lukyanov; Dmitriy M Chudakov
Journal:  Nat Methods       Date:  2007-08-26       Impact factor: 28.547

5.  Replication of subgenomic hepatitis C virus replicons in mouse fibroblasts is facilitated by deletion of interferon regulatory factor 3 and expression of liver-specific microRNA 122.

Authors:  Liang-Tzung Lin; Ryan S Noyce; Tram N Q Pham; Joyce A Wilson; Gary R Sisson; Thomas I Michalak; Karen L Mossman; Christopher D Richardson
Journal:  J Virol       Date:  2010-06-30       Impact factor: 5.103

6.  Reconstitution of the entire hepatitis C virus life cycle in nonhepatic cells.

Authors:  Daniel Da Costa; Marine Turek; Daniel J Felmlee; Erika Girardi; Sébastien Pfeffer; Gang Long; Ralf Bartenschlager; Mirjam B Zeisel; Thomas F Baumert
Journal:  J Virol       Date:  2012-08-15       Impact factor: 5.103

7.  Targeted disruption of IRF-1 or IRF-2 results in abnormal type I IFN gene induction and aberrant lymphocyte development.

Authors:  T Matsuyama; T Kimura; M Kitagawa; K Pfeffer; T Kawakami; N Watanabe; T M Kündig; R Amakawa; K Kishihara; A Wakeham
Journal:  Cell       Date:  1993-10-08       Impact factor: 41.582

Review 8.  Towards a small animal model for hepatitis C.

Authors:  Alexander Ploss; Charles M Rice
Journal:  EMBO Rep       Date:  2009-10-16       Impact factor: 8.807

9.  Deficient signaling in mice devoid of double-stranded RNA-dependent protein kinase.

Authors:  Y L Yang; L F Reis; J Pavlovic; A Aguzzi; R Schäfer; A Kumar; B R Williams; M Aguet; C Weissmann
Journal:  EMBO J       Date:  1995-12-15       Impact factor: 11.598

10.  Expression of heterologous proteins flanked by NS3-4A cleavage sites within the hepatitis C virus polyprotein.

Authors:  Joshua A Horwitz; Marcus Dorner; Tamar Friling; Bridget M Donovan; Alexander Vogt; Joana Loureiro; Thomas Oh; Charles M Rice; Alexander Ploss
Journal:  Virology       Date:  2013-02-26       Impact factor: 3.616

View more
  30 in total

Review 1.  Unexpected structural features of the hepatitis C virus envelope protein 2 ectodomain.

Authors:  Ali Sabahi; Susan L Uprichard; William C Wimley; Srikanta Dash; Robert F Garry
Journal:  J Virol       Date:  2014-07-02       Impact factor: 5.103

2.  Mice Expressing Minimally Humanized CD81 and Occludin Genes Support Hepatitis C Virus Uptake In Vivo.

Authors:  Qiang Ding; Markus von Schaewen; Gabriela Hrebikova; Brigitte Heller; Lisa Sandmann; Mario Plaas; Alexander Ploss
Journal:  J Virol       Date:  2017-01-31       Impact factor: 5.103

Review 3.  Hepatitis C virus and antiviral innate immunity: who wins at tug-of-war?

Authors:  Da-Rong Yang; Hai-Zhen Zhu
Journal:  World J Gastroenterol       Date:  2015-04-07       Impact factor: 5.742

4.  Production and characterization of high-titer serum-free cell culture grown hepatitis C virus particles of genotype 1-6.

Authors:  Christian K Mathiesen; Tanja B Jensen; Jannick Prentoe; Henrik Krarup; Alfredo Nicosia; Mansun Law; Jens Bukh; Judith M Gottwein
Journal:  Virology       Date:  2014-05-24       Impact factor: 3.616

Review 5.  Protein Interactions during the Flavivirus and Hepacivirus Life Cycle.

Authors:  Gisa Gerold; Janina Bruening; Bettina Weigel; Thomas Pietschmann
Journal:  Mol Cell Proteomics       Date:  2017-01-11       Impact factor: 5.911

Review 6.  The impact of hepatitis C virus entry on viral tropism.

Authors:  Qiang Ding; Markus von Schaewen; Alexander Ploss
Journal:  Cell Host Microbe       Date:  2014-11-12       Impact factor: 21.023

Review 7.  Genetic Dissection of the Host Tropism of Human-Tropic Pathogens.

Authors:  Florian Douam; Jenna M Gaska; Benjamin Y Winer; Qiang Ding; Markus von Schaewen; Alexander Ploss
Journal:  Annu Rev Genet       Date:  2015-09-25       Impact factor: 16.830

8.  Butyrate Reprograms Expression of Specific Interferon-Stimulated Genes.

Authors:  Mahesh Chemudupati; Adam D Kenney; Anna C Smith; Robert J Fillinger; Lizhi Zhang; Ashley Zani; Shan-Lu Liu; Matthew Z Anderson; Amit Sharma; Jacob S Yount
Journal:  J Virol       Date:  2020-07-30       Impact factor: 5.103

Review 9.  Murine models of hepatitis C: what can we look forward to?

Authors:  Markus von Schaewen; Alexander Ploss
Journal:  Antiviral Res       Date:  2014-01-24       Impact factor: 5.970

10.  Hepacivirus NS3/4A Proteases Interfere with MAVS Signaling in both Their Cognate Animal Hosts and Humans: Implications for Zoonotic Transmission.

Authors:  Richard J P Brown; Dominic H Banda; Daniel Todt; Gabrielle Vieyres; Eike Steinmann; Thomas Pietschmann
Journal:  J Virol       Date:  2016-11-14       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.